Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | JAK1 | P23458 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9367810 | 0.86 | GAA (0.53) | GAACDK1MAPTTP53GLA | |
| SCHEMBL55236 | 0.83 | GAA (0.52) | GAACDK1MAPTTP53GLA | |
| SCHEMBL8535700 | 0.83 | GAA (0.52) | GAACDK1MAPTTP53GLA | |
| SCHEMBL9517317 | 0.82 | GAA (0.48) | GAACDK1MAPTTP53GLA | |
| SCHEMBL9367730 | 0.81 | GAA (0.48) | GAACDK1MAPTTP53GLA | |
| SCHEMBL169995 | 0.80 | GAA (0.47) | GAACDK1MAPTTP53GLA | |
| SCHEMBL3498696 | 0.80 | GAA (0.51) | GAACDK1MAPTTP53GLA | |
| SCHEMBL9362787 | 0.79 | GAA (0.46) | GAACDK1MAPTTP53GLA | |
| SCHEMBL9362781 | 0.78 | GAA (0.46) | GAACDK1MAPTTP53GLA | |
| SCHEMBL12633039 | 0.78 | GAA (0.46) | GAACDK1MAPTTP53GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138122-B2 | Comprising imazosulfuron and a pyrimidine-substituted imidazopyrazine compound; excellent herbicidal activity for controlling weeds in crop fields, or paddy fields, and causes no phytotoxicity against useful plants | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-20 | — | — | US | disclosed |
| US-20090186763-A1 | HERBICIDAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186763-A1 | HERBICIDAL COMPOSITION | DDT, GMDS, DDC | GAA 1215/4885CDK1 1144/4885MAPT 2514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.